Company / Working Capital
Bio-Techne Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$432.5M
FY2025
5-year range
$358.3M / $493.0M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#69 of 160
Health Care
What the data says
At $432M, Bio-Techne's working capital ranks #69 of 160 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $200M in FY2016 to $493M in FY2023.
Based on SEC 10-K filings.
$432M in FY2025 with a 5-year CAGR of +0.9%.
Declined from $493M to $432M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
#69 of 160 in Health CareTop 43% of 160This company $432.5M Sector average $757.1M
▼
-42.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.9%, indicating consistent growth.
- In FY2025, working capital decreased 5.6% year-over-year.
- Ranks #69 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $432.5M | -5.6% |
| FY2024 | $458.0M | -7.1% |
| FY2023 | $493.0M | +14.8% |
| FY2022 | $429.5M | +19.9% |
| FY2021 | $358.3M | -13.5% |
| FY2020 | $414.3M | +33.4% |
| FY2019 | $310.6M | -2.6% |
| FY2018 | $318.9M | +50.0% |
| FY2017 | $212.5M | +6.4% |
| FY2016 | $199.7M | -4.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026